African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2284

Notice of Retraction: Preparation and characterization of crosslinked and non-crosslinked polycaprolactone fumarate (PCLF) NPs as carriers for doxorubicin HCl

Narges Shokri
  • Narges Shokri
  • Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, 16 Azar Street, Engelab Sq, P. O. Box 14155-6451, Tehran, Iran.
  • Google Scholar
Hamid Akbari Javar
  • Hamid Akbari Javar
  • Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, 16 Azar Street, Engelab Sq, P. O. Box 14155-6451, Tehran, Iran & Department of Pharmacy, University of Malaya, Malaysia.
  • Google Scholar
Shamileh Fouladdel
  • Shamileh Fouladdel
  • Department of Pharmacology and Toxicology, Molecular Research Lab, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Google Scholar
Ali Khalaj
  • Ali Khalaj
  • Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Google Scholar
Rasoul Dinarvand
  • Rasoul Dinarvand
  • Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, 16 Azar Street, Engelab Sq, P. O. Box 14155-6451, Tehran, Iran & Medical Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Google Scholar
Ebrahim Azizi
  • Ebrahim Azizi
  • Department of Pharmacology and Toxicology, Molecular Research Lab, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Google Scholar


  •  Received: 13 November 2020
  •  Accepted: 13 November 2020
  •  Published: 30 November 2020

Abstract

The editors of the African Journal of Pharmacy and Pharmacology (AJPP) are retracting the article, “Preparation and characterization of crosslinked and non-crosslinked polycaprolactone fumarate (PCLF) NPs as carriers for doxorubicin HCl” published in 2011 (Vol. 5(7), pp. 797-805, July 2011). This is based on evidences of text overlap (in figures and tables) between the article and those published in two other journals: International Journal of Pharmaceutical Sciences and Research (Vol. 3(9):3106-3115, 2012) and Daru (Vol. 19(1):12-22; 2011)

Hence, this is a case of redundant publication.